Under construction – not a live service
Sign in
Taking people in SloveniaNo phase

Studies outcomes of people with nose, sinus and skull-base tumours

Observes people with nasal, sinus and skull-base tumours and how they are treated.

Plain-language title generated from the registry record
Registry title: Prospective Study of Sinonasal and Skull-base Tumours Management

Key facts

Where
Ljubljana, SloveniaSee the site

Where in Slovenia

  • University Medical Centre LjubljanaLjubljana, SloveniaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Medical Centre Ljubljana
Trial code
NCT05607888
Record updated
29 April 2026
Original description
This observational prospective clinical study aims to describe the epidemiology, management and outcome of patients with sinonasal and skull-base pathology (tumours and diseases with malignant clinical characteristics) in a tertiary otorhinolaryngology referral centre. The main questions it aims to answer are:Read full original descriptionShow less

Prospective Observational Study of Sinonasal and Skull-base Tumours Management in a Tertiary Referral Otorhinolaryngology Service

This observational prospective clinical study aims to describe the epidemiology, management and outcome of patients with sinonasal and skull-base pathology (tumours and diseases with malignant clinical characteristics) in a tertiary otorhinolaryngology referral centre. The main questions it aims to answer are:

* what is the caseload of patients with the included pathology in our centre * what are the results of management of these cases * what are the epidemiological characteristics of included patients * what is the quality of life of included patients.

Inclusion: sinonasal and/or skull-base cancer; sinonasal disease expanding through the skull-base; the patient's written informed consent.

Exclusion: lateral skull-base disease primarily originating in the temporal bone and without central skull-base involvement.

ClinicalTrials.gov NCT05607888